EconPapers    
Economics at your fingertips  
 

PharmacoEconomics - Open

2017 - 2020

Current editor(s): Timothy Wrightson and Christopher Carswell

From Springer
Bibliographic data for series maintained by Sonal Shukla ().

Access Statistics for this journal.
Track citations for all items by RSS feed
Is something missing from the series or not right? See the RePEc data check for the archive and series.


2020, volume 4, issue 1

Registered Reports: Time to Radically Rethink Peer Review in Health Economics pp. 1-4 Downloads
Philip Clarke, John Buckell and Adrian Barnett
Systematic Review of Economic Evaluations in Primary Open-Angle Glaucoma: Decision Analytic Modeling Insights pp. 5-12 Downloads
Jose Bartelt-Hofer, Lilia Ben-Debba and Steffen Flessa
Health State Utility Data in Cystic Fibrosis: A Systematic Review pp. 13-25 Downloads
Bishal Mohindru, David Turner, Tracey Sach, Diana Bilton, Siobhan Carr, Olga Archangelidi, Arjun Bhadhuri and Jennifer A. Whitty
The Health System Costs of Potentially Inappropriate Prescribing: A Population-Based, Retrospective Cohort Study Using Linked Health Administrative Databases in Ontario, Canada pp. 27-36 Downloads
Cody D. Black, Kednapa Thavorn, Doug Coyle and Lise M. Bjerre
The Use of Computer Simulation Modeling to Estimate Complications in Patients with Type 2 Diabetes Mellitus: Comparative Validation of the Cornerstone Diabetes Simulation Model pp. 37-44 Downloads
Zhuo T. Su, Jose Bartelt-Hofer, Stephen Brown, Elisheva Lew, Luc Sauriol, Lieven Annemans and Daniel T. Grima
Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa pp. 45-60 Downloads
S. Boyer, M. L. Nishimwe, L. Sagaon-Teyssier, L. March, S. Koulla-Shiro, Marwân-al-Qays Bousmah, R. Toby, M. P. Mpoudi-Etame, N. F. Ngom Gueye, A. Sawadogo, C. Kouanfack, L. Ciaffi, B. Spire and E. Delaporte
An Evaluation of Diagnosis-Related Group (DRG) Implementation Focused on Cancer DRGs in Greek Public Hospitals pp. 61-69 Downloads
Panos Panagiotopoulos, Nikos Maniadakis, George Papatheodoridis and Dimitris Pektasidis
Return on Investment of Free Colorectal Cancer Screening Tests in a Primarily Rural Uninsured or Underinsured Population in Northeast Texas pp. 71-77 Downloads
Gabriela Orsak, Anastasia Miller, Carlton M. Allen, Karan P. Singh and Paul McGaha
Cost Effectiveness of Mirabegron Compared with Antimuscarinic Agents for the Treatment of Adults with Overactive Bladder in Colombia pp. 79-90 Downloads
Hélène Parise, Robert Espinosa, Katherine Dea, Pablo Anaya, Giovanny Montoya and Daniel Bin Ng
Healthcare, Sickness Absence, and Disability Pension Cost Trajectories in the First 5 Years After Diagnosis with Multiple Sclerosis: A Prospective Register-Based Cohort Study in Sweden pp. 91-103 Downloads
Korinna Karampampa, Hanna Gyllensten, Fei Yang, Chantelle Murley, Emilie Friberg, Jan Hillert and Kristina Alexanderson
Impact of Plan-Level Access Restrictions on Effectiveness of Biologics Among Patients with Rheumatoid or Psoriatic Arthritis pp. 105-117 Downloads
Natalie Boytsov, Xiang Zhang, Kristin A. Evans and Barbara H. Johnson
US Integrated Delivery Networks Perspective on Economic Burden of Patients with Treatment-Resistant Depression: A Retrospective Matched-Cohort Study pp. 119-131 Downloads
Dominic Pilon, Holly Szukis, Kruti Joshi, David Singer, John J. Sheehan, Jennifer W. Wu, Patrick Lefebvre and Paul Greenberg
Cost-Effectiveness Analysis of Recombinant Factor VIII Fc-Fusion Protein (rFVIIIFc) for the Treatment of Severe Hemophilia A in Italy Incorporating Real-World Dosing and Joint Health Data pp. 133-142 Downloads
Ash Bullement, Samuel Thomas McMordie, Anthony James Hatswell, Nanxin Li and Koo Wilson
Early Economic Evaluation to Identify the Necessary Test Characteristics of a New Typhoid Test to be Cost Effective in Ghana pp. 143-157 Downloads
Samuel N. Frempong, Andrew J. Sutton, Clare Davenport and Pelham Barton
A Cost-Effectiveness Analysis Comparing the VivaSight Double-Lumen Tube and a Conventional Double-Lumen Tube in Adult Patients Undergoing Thoracic Surgery Involving One-Lung Ventilation pp. 159-169 Downloads
Sara Larsen, Jimmy Højberg Holm, Tove Nørgaard Sauer and Claus Andersen
Buccal Midazolam Solution for the Management of Prolonged Acute Convulsive Seizures: A Cost Analysis pp. 171-179 Downloads
Catherine Ludwig and Lauri Fisher
Medical Costs of Patients with Type 2 Diabetes in a Single Payer System: A Classification and Regression Tree Analysis pp. 181-190 Downloads
Paola Rucci, Vera Maria Avaldi, Claudio Travaglini, Cristina Ugolini, Elena Berti, Maria Luisa Moro and Maria Pia Fantini
Symptoms and Dietary Impact in Hypertriglyceridemia-Associated Pancreatitis: Development and Content Validity of Two New Measures pp. 191-201 Downloads
Claire Burbridge, Jason A. Randall, Robert J. Sanchez, Hayes Dansky, Tara Symonds, Cynthia J. Girman, Joshua A. Strayer, Karen L. Selk, David C. Whitcomb and Erin E. Kershaw

2019, volume 3, issue 4

Check Your Checklist: The Danger of Over- and Underestimating the Quality of Economic Evaluations pp. 433-435 Downloads
Geert W. J. Frederix
A Comparison of Pharmaceutical Budget Impact Analysis (BIA) Recommendations Amongst the Canadian Patented Medicine Prices Review Board (PMPRB), Public and Private Payers pp. 437-451 Downloads
Naghmeh Foroutan, Jean-Eric Tarride, Feng Xie, Fergal Mills and Mitchell Levine
Cenegermin for Treating Neurotrophic Keratitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal pp. 453-461 Downloads
Nigel Fleeman, James Mahon, Sarah Nevitt, Rui Duarte, Angela Boland, Eleanor Kotas, Yenal Dundar, Joanne McEntee and Sajjad Ahmad
Economic Burden and Health-Related Quality of Life Associated with Current Treatments for Anaemia in Patients with CKD not on Dialysis: A Systematic Review pp. 463-478 Downloads
Pablo E. Pergola, Roberto Pecoits-Filho, Wolfgang C. Winkelmayer, Bruce Spinowitz, Samuel Rochette, Philippe Thompson-Leduc, Patrick Lefebvre, Gigi Shafai, Ana Bozas, Myrlene Sanon and Holly B. Krasa
A Systematic Review of the Health Economics of Pompe Disease pp. 479-493 Downloads
Benedikt Schoser, Andreas Hahn, Emma James, Digant Gupta, Matthew Gitlin and Suyash Prasad
Person-Centred Care in Patients with Acute Coronary Syndrome: Cost-Effectiveness Analysis Alongside a Randomised Controlled Trial pp. 495-504 Downloads
Laura Pirhonen, Kristian Bolin, Elisabeth Hansson Olofsson, Andreas Fors, Inger Ekman, Karl Swedberg and Hanna Gyllensten
Cost-Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV-1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM) pp. 505-515 Downloads
Osvaldo Ulises Garay, Marie Libérée Nishimwe, Marwân-al-Qays Bousmah, Asmaa Janah, Pierre-Marie Girard, Geneviève Chêne, Laetitia Moinot, Luis Sagaon-Teyssier, Jean-Luc Meynard, Bruno Spire and Sylvie Boyer
National Health Insurance Databases in Indonesia, Vietnam and the Philippines pp. 517-526 Downloads
Junice Yi Siu Ng, Royasia Viki Ramadani, Donni Hendrawan, Duong Tuan Duc and Pham Huy Tuan Kiet
Use of Initial Noninvasive Cardiac Testing and Association with Downstream Healthcare Resource: A Retrospective Review of Resources Used Across a 12-Month Window for Probable Type I Myocardial Infarction Patients pp. 527-535 Downloads
Dana Villines, Wm. Thomas Summerfelt, James R. Spalding, Therese M. Kitt, Rita M. Kristy and Christy R. Houle
Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada pp. 537-550 Downloads
Pierre Johansen, Jonas Håkan-Bloch, Aiden R. Liu, Peter G. Bech, Sofie Persson and Lawrence A. Leiter
Using Time Trade-Off Methods to Elicit Short-Term Utilities Associated with Treatments for Bulbar Urethral Stricture pp. 551-558 Downloads
Jing Shen, Matthew Breckons, Luke Vale and Robert Pickard
Cost-Effectiveness Analysis of Fulvestrant 500 mg in Endocrine Therapy-Naïve Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer in the UK pp. 559-570 Downloads
Claire Telford, Evelina Bertranou, Samuel Large, Hilary Phelps, Mattias Ekman and Christopher Livings
Using a Discrete-Choice Experiment to Estimate the Preferences of Clinical Practitioners for a Novel Non-invasive Device for Diagnosis of Peripheral Arterial Disease in Primary Care pp. 571-581 Downloads
Yemi Oluboyede, Laura Ternent, Luke Vale and John Allen
Analysis of Health Technology Assessments of Orphan Drugs in Ireland from 2012 to 2017 pp. 583-589 Downloads
Cara Usher, Laura McCullagh, Lesley Tilson and Michael Barry
The Costs of Industry-Sponsored Medical Device Clinical Trials in Alberta pp. 591-597 Downloads
Ilke Akpinar, Arto Ohinmaa, Lars Thording, Dat T. Tran, Richard N. Fedorak, Lawrence Richer and Philip Jacobs
Long-Term Inpatient Hospital Utilisation and Costs (2007–2008 to 2015–2016) for Publicly Waitlisted Bariatric Surgery Patients in an Australian Public Hospital System Based on Australia’s Activity-Based Funding Model pp. 599-618 Downloads
Julie Campbell, Martin Hensher, Daniel Davies, Matthew Green, Barry Hagan, Ian Jordan, Alison Venn, Alexandr Kuzminov, Amanda Neil, Stephen Wilkinson and Andrew J. Palmer
Smart Pump–Electronic Health Record (EHR) Interoperability with Auto-Documentation is Associated with Increased Submission of Infusion-Therapy Billing Claims at a Community Hospital pp. 619-629 Downloads
Tina M. Suess, John W. Beard, Michael Ripchinski, Matthew Eberts, Kevin Patrick and Leo J. P. Tharappel
A Cost Analysis of Haemodialysis and Peritoneal Dialysis for the Management of End-Stage Renal Failure At an Academic Hospital in Pretoria, South Africa pp. 631-641 Downloads
Letlhogonolo Makhele, Moliehi Matlala, Mncengeli Sibanda, Antony P. Martin and Brian Godman
Indonesian Social Health Insurance Sample Data are Now Available and Accessible for Research pp. 643-645 Downloads
Anis Fuad
Correction to: A Cost Analysis of Haemodialysis and Peritoneal Dialysis for the Management of End-Stage Renal Failure At an Academic Hospital in Pretoria, South Africa pp. 647-647 Downloads
Letlhogonolo Makhele, Moliehi Matlala, Mncengeli Sibanda, Antony P. Martin and Brian Godman

2019, volume 3, issue 3

Extending Life in Duchenne Muscular Dystrophy: Implications for Appraisals of Cost-Effectiveness pp. 279-280 Downloads
Erik Landfeldt
Use of Decision Modelling in Economic Evaluations of Diagnostic Tests: An Appraisal and Review of Health Technology Assessments in the UK pp. 281-291 Downloads
Yaling Yang, Lucy Abel, James Buchanan, Thomas Fanshawe and Bethany Shinkins
Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal pp. 293-302 Downloads
Nigel Fleeman, Adrian Bagust, Rui Duarte, Marty Richardson, Sarah Nevitt, Angela Boland, Eleanor Kotas, Joanne McEntee and Nicky Thorp
Evolution of Average European Medicine Prices: Implications for the Methodology of External Price Referencing pp. 303-309 Downloads
Sabine Vogler, Peter Schneider and Nina Zimmermann
The Worth of a Quality-Adjusted Life-Year in Patients with Diabetes: An Investigation Study using a Willingness-to-Pay Method pp. 311-319 Downloads
Najme Moradi, Arash Rashidian, Shirin Nosratnejad, Alireza Olyaeemanesh, Marzieh Zanganeh and Leila Zarei
Economic Evaluation of Nivolumab Plus Ipilimumab Combination as First-Line Treatment for Patients with Advanced Melanoma in Canada pp. 321-331 Downloads
Peter L. Quon, Ying Xiao, Sonja Sorensen and Amir Abbas Tahami Monfared
Economic Impact and Clinical Outcomes of Omalizumab Add-On Therapy for Patients with Severe Persistent Asthma: A Real-World Study pp. 333-342 Downloads
Luis Manuel Entrenas Costa, Francisco Casas-Maldonado, José Gregorio Soto Campos, Alicia Padilla-Galo, Alberto Levy, Francisco Javier Álvarez Gutiérrez, Ana P. Gómez-Bastero Fernández, Concepción Morales-García, Rocío Gallego Domínguez, Gustavo Villegas Sánchez, Luis Mateos Caballero, Antonio Pereira-Vega, Cayo García Polo, Gerardo Pérez Chica and Juan José Martín Villasclaras
Estimated Versus Observed Expenditure Associated with Medicines Recommended by the All Wales Medicines Strategy Group pp. 343-350 Downloads
Stuart Keeping, Paul N. Deslandes, Kathryn E. Haines and Philip A. Routledge
The Role of Real-World Evidence in UK Reimbursement: Case Study of Lenalidomide in Myelodysplastic Syndrome Deletion 5q pp. 351-358 Downloads
Dawn Lee, Nic Brereton, Sujith Dhanasiri and Austin Kulasekararaj
Remote Monitoring of Patient-Reported Outcomes in Ulcerative Colitis: A Prospective Real-World Pilot Study pp. 359-365 Downloads
Shaji Sebastian, Jenna Roberts, John Waller, Davneet Judge, Chloe Brown, Ruth Davies and Sumesh Kachroo
Associations between Health-Related Quality of Life and Self-Reported Emergency Room Department Visits and Inpatient Hospitalizations: Insights from a Secondary Data Analysis of Patients with Light-Chain (AL) Amyloidosis pp. 367-375 Downloads
Kristen L. McCausland, Avery A. Rizio, Michelle K. White, Martha S. Bayliss and Tiffany P. Quock
Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma pp. 377-390 Downloads
Ash Bullement, Paul Nathan, Anna Willis, Amerah Amin, Cameron Lilley, Ceilidh Stapelkamp, Anthony Hatswell, Chris Pescott and Murtuza Bharmal
Cost of Treatment of Valvular Heart Disease at a Tertiary Hospital in North India: Policy Implications pp. 391-402 Downloads
Shankar Prinja, Yashpaul Sharma, Jyoti Dixit, Shyam Kumar Singh Thingnam and Rajesh Kumar
A Review of Issues Affecting the Efficiency of Decision Making in the NICE Single Technology Appraisal Process pp. 403-410 Downloads
M. J. Walton, J. O’Connor, C. Carroll, L. Claxton and R. Hodgson
Costs of Acute Headache Medication Use and Productivity Losses Among Patients with Migraine: Insights from Three Randomized Controlled Trials pp. 411-417 Downloads
Joshua K. Porter, Gian Luca Di Tanna, Richard B. Lipton, Sandhya Sapra and Guillermo Villa
All-Male Panels and Gender Diversity of Issue Panels and Plenary Sessions at ISPOR Europe pp. 419-422 Downloads
Jacoline C. Bouvy and Michelle Mujoomdar
All Male Panels and Other Diversity Considerations for ISPOR pp. 423-426 Downloads
Nancy Devlin
Correction to: Conducting a Time Trade-Off Study Alongside a Clinical Trial: A Case Study and Recommendations pp. 427-427 Downloads
Jing Shen, Sarah Hill, David Mott, Matthew Breckons, Luke Vale and Rob Pickard

2019, volume 3, issue 2

Evaluating the Outcomes Associated with Genomic Sequencing: A Roadmap for Future Research pp. 129-132 Downloads
James Buchanan and Sarah Wordsworth
Working with Patients and Members of the Public: Informing Health Economics in Child Health Research pp. 133-141 Downloads
Rebecca Kandiyali, Annie Hawton, Christie Cabral, Julie Mytton, Valerie Shilling, Christopher Morris and Jenny Ingram
Measuring the Benefits of Decision Aids for Economic Evaluation pp. 143-150 Downloads
Thomas Butt
Strimvelis® for Treating Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency: An Evidence Review Group Perspective of a NICE Highly Specialised Technology Evaluation pp. 151-161 Downloads
Emily South, Edward Cox, Nick Meader, Nerys Woolacott and Susan Griffin
Uterotonic Drugs for the Prevention of Postpartum Haemorrhage: A Cost-Effectiveness Analysis pp. 163-176 Downloads
Karen Pickering, Ioannis D. Gallos, Helen Williams, Malcolm J. Price, Abi Merriel, David Lissauer, Aurelio Tobias, G. Justus Hofmeyr, Arri Coomarasamy and Tracy E. Roberts
Adherence, Healthcare Resource Utilization, and Costs in Medicaid Beneficiaries with Schizophrenia Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate pp. 177-188 Downloads
Bruno Emond, Kruti Joshi, Antoine C. El Khoury, Marie-Hélène Lafeuille, Dominic Pilon, Neeta Tandon, Hela Romdhani and Patrick Lefebvre
Cost Comparison of Single-Use Versus Reusable Bronchoscopes Used for Percutaneous Dilatational Tracheostomy pp. 189-195 Downloads
Anne Sohrt, Lars Ehlers, Flemming Witt Udsen, Anders Mærkedahl and Brendan A. McGrath
The Psychometric Properties of a Self-Administered, Open-Source Module for Valuing Metastatic Epidural Spinal Cord Compression Utilities pp. 197-204 Downloads
Markian Pahuta, Aaron Frombach, Emile Hashem, Stewart Spence, Christina Sun, Eugene K. Wai, Joel Werier, Carl Walraven and Doug Coyle
High Healthcare Resource Use in Hospitalized Patients with a Diagnosis of Spinal Muscular Atrophy Type 1 (SMA1): Retrospective Analysis of the Kids’ Inpatient Database (KID) pp. 205-213 Downloads
Jessica Cardenas, Melissa Menier, Marjet D. Heitzer and Douglas M. Sproule
Does Structured Exercise Improve Cognitive Impairment in People with Mild to Moderate Dementia? A Cost-Effectiveness Analysis from a Confirmatory Randomised Controlled Trial: The Dementia and Physical Activity (DAPA) Trial pp. 215-227 Downloads
Iftekhar Khan, Stavros Petrou, Kamran Khan, Dipesh Mistry, Ranjit Lall, Bart Sheehan and Sarah Lamb
Time and Cost of Hospitalisation for Salvage Therapy in Adults with Philadelphia Chromosome-Negative B Cell Precursor Relapsed or Refractory Acute Lymphoblastic Leukaemia in Spain pp. 229-235 Downloads
Blanca Boluda, Rebeca Rodríguez-Veiga, David Martínez-Cuadrón, Ignacio Lorenzo, Jaime Sanz, Ana Regadera, Amparo Sempere, Leonor Senent, Jose Vicente Cervera, Pilar Solves, John Reitan, Salvador Gea, Miguel Angel Sanz and Pau Montesinos
Economic Burden of Patients Treated for Higher-Risk Myelodysplastic Syndromes (HR-MDS) in Routine Clinical Care in the United States pp. 237-245 Downloads
Jill A. Bell, Aaron Galaznik, Marlo Blazer, Huai-Che Shih, Eileen Farrelly, Augustina Ogbonnaya, Michael Eaddy, Robert J. Fram and Douglas V. Faller
Economics of Acromegaly Treatment in Brazil: A Budget Impact Analysis of Pituitary Surgery Compared with Long-Term Octreotide LAR pp. 247-254 Downloads
Lara Benigno Porto, Ivan Ricardo Zimmermann and Luciana Ansaneli Naves
Patient and Physician Preferences for Therapy Characteristics for Psoriasis: A Discrete Choice Experiment in Japan pp. 255-264 Downloads
Timothy Bolt, Hisanori Kobayashi and Jörg Mahlich
Cost-Effectiveness Analysis of Single-Use EEG Cup Electrodes Compared with Reusable EEG Cup Electrodes pp. 265-272 Downloads
Anne Sohrt, Anders Mærkedahl and William V. Padula
Correction to: Cost-Effectiveness Analysis of Single-Use EEG Cup Electrodes Compared with Reusable EEG Cup Electrodes pp. 273-273 Downloads
Anne Sohrt, Anders Mærkedahl and William V. Padula
Correction to: Cost-Effectiveness Analysis of Single-Use EEG Cup Electrodes Compared with Reusable EEG Cup Electrodes pp. 275-275 Downloads
Anne Sohrt, Anders Mærkedahl and William V. Padula
Correction to: Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery Disease pp. 277-277 Downloads
James Lomas, Miqdad Asaria, Laura Bojke, Chris P. Gale, Gerry Richardson and Simon Walker

2019, volume 3, issue 1

Value Assessment Frameworks in the United States: A Call for Patient Engagement pp. 1-3 Downloads
Vakaramoko Diaby, Askal A. Ali and Alberto J. Montero
Conducting a Time Trade-Off Study Alongside a Clinical Trial: A Case Study and Recommendations pp. 5-20 Downloads
Jing Shen, Sarah Hill, David Mott, Matthew Breckons, Luke Vale and Rob Pickard
Systematic Review of Economic Models Used to Compare Techniques for Detecting Peripheral Arterial Disease pp. 21-30 Downloads
Eoin Moloney, Joanne O’Connor, Dawn Craig, Shannon Robalino, Alexandros Chrysos, Mehdi Javanbakht, Andrew Sims, Gerard Stansby, Scott Wilkes and John Allen
Accommodation and Health Costs of Deinstitutionalized People with Mental Illness Living in Residential Services in Brazil pp. 31-42 Downloads
Denise Razzouk
Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in England pp. 43-54 Downloads
D. Lee, A. Amadi, J. Sabater, J. Ellis, H. Johnson, S. Kotapati, S. McNamara, A. Walker, M. Cooper, K. Patterson, N. Roskell and Y. Meng
Reduction of Direct Health Costs Associated with Pertussis Vaccination with Acellular Vaccines in Children Aged 0–9 Years with Pertussis in Catalonia (Spain) pp. 55-69 Downloads
Pedro Plans-Rubió, Encarna Navas, Pere Godoy, Gloria Carmona, Angela Domínguez, Mireia Jané, Carmen Muñoz-Almagro and Pedro Brotons
Assessing the Impact of Growth Hormone Deficiency (GHD) in Adults: Interpreting Change of the Treatment-Related Impact Measure—Adult Growth Hormone Deficiency (TRIM-AGHD) pp. 71-80 Downloads
Meryl Brod, Jane F. Beck, Lise Højbjerre, Donald M. Bushnell, Johan Erpur Adalsteinsson, Lars Wilkinson and Michael Højby Rasmussen
Influence of Idiopathic Pulmonary Fibrosis Progression on Healthcare Resource Use pp. 81-91 Downloads
Alex Diamantopoulos, Toby M. Maher, Nils Schoof, Dirk Esser and Corinne LeReun
Cost Effectiveness of Long-Term Incobotulinumtoxin-A Treatment in the Management of Post-stroke Spasticity of the Upper Limb from the Australian Payer Perspective pp. 93-102 Downloads
Koji Makino, Dominic Tilden, Carmel Guarnieri, Mia Mudge and Ian J. Baguley
International HTA Experience with Targeted Therapy Approvals for Lung Cancer pp. 103-117 Downloads
Fatma Maraiki, Joshua Byrnes, H. Tuffaha and M. Hinder
Evaluation of the Impact of an Institution-Specific Dofetilide Initiation Protocol on Mean Hospital Length of Stay and Cost for Dofetilide Initiation pp. 119-126 Downloads
Steven P. Kennedy, Hanna Iaizzo, Evgueni Fayn and Dalip Singh
Correction to: Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in England pp. 127-127 Downloads
D. Lee, A. Amadi, J. Sabater, J. Ellis, H. Johnson, S. Kotapati, S. McNamara, A. Walker, M. Cooper, K. Patterson, N. Roskell and Y. Meng
Page updated 2020-04-04